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Abstract
The retinal ganglion cells (RGCs) from porcine eyes were extracted to work towards a
potential therapy for glaucoma. There is not a known cause of glaucoma or the apoptosis of
RGCs that cause the eventual blindness associated with glaucoma. The goal of this protocol
is to protect the RGCs from dying by adding a nicotinic acetylcholine receptor activator to
induce neuronal proliferation and protect against glutamate-induced excitotoxicity. PNU
282987 was used as the nicotinic acetylcholine receptor activator due to its neuroprotective
properties. We hypothesized that we would observe the proliferation of RGCs (associated
with increased cell numbers) with varying levels of PNU 282987 compared to a set of
untreated control plates. For each protocol three plates labelled A were left untreated, three
plates labelled B were treated with 40 μL of PNU 282987 (100 μM), and three plates
labelled C were treated with 80 μL of PNU 282987 (200 μM). We analyzed pictures of the
plates using Image J. The average cell count and average area were analyzed for our
purposes to check for the proliferation of RGCs and determine the size of the cells that
survived and replicated. Although there seemed to be an increased average cell count in
plates B compared to plates A and C and an increase in average area in plates C compared to
plates A and B, our data did not have statistical significance. Further experiments will have
to be conducted to determine if PNU 282987 significantly induces the proliferation of
RGCs, and if its neuroprotective properties can be used as a potential treatment for
glaucoma or provide further insight into the cause of this disease.
Introduction
Glaucoma is an ocular neurodegenerative disease that is caused by the death of retinal
ganglion cells (RGCs) and their axons which eventually leads to blindness.1–6 RGCs interact
indirectly with the photoreceptors that receive the light that enters the eye. RGCs, whose
axons form the optic nerve, transmits the image to our brain to be interpreted. These RGCs
die via apoptosis presumably due to glutamate-induced excitotoxicity.3–7 Müller glia cells
usually are responsible for protecting neurons such as RGCs against glutamate-induced
excitotoxicity by clearing glutamate.8,9 Many have believed that an increase in intraocular
pressure (IOP) is a cause of glaucoma, yet there are patients with normotensive (normal IOP)
glaucoma. But there seems to be strong correlation between a high IOP and the degeneration
of RGCs. If one already has glaucoma, an increased IOP has been correlated with faster
development of glaucoma.2 An elevated IOP has been shown to be followed by a decrease in
mitochondria in the optic nerve.10,11 It can be unsafe to alter a patient’s blood pressure in
order to attempt to lower the IOP2, so other treatment options for glaucoma such as directly
addressing the death of RGCs may be a safer and more effective option for patients.
Large RGCs seem to be targeted especially during apoptosis, but RGCs of all sizes are
affected by this disease.5 The death of the axons negatively affects vision due to the loss of
transportation of substances between the cell body and axon terminal. This could cause the
RGCs to die due to an intracellular electrolyte imbalance or microglial phagocytosis.12
RGC regeneration has been seen in other organisms, for example the zebrafish.13,14 Once
the RGCs have sustained damage, Müller glia are induced to dedifferentiate into multipotent
neural progenitor cells.8,9 These cells move to the damaged region of the retina and
differentiate into the cell type that was damaged.14 Due to the successful regeneration of

retinal cells in other organisms, we believe that this line of research can be extended to
mammalian retinas, specifically porcine retinas. It has been shown that insulin growth factor
inhibitors can halt the proliferation of certain tissues.14 In order to combat this, we enrich the
second media with insulin, transferrin and nerve-growth factor. Importantly, a recent study
has shown that Müller glia are involved in the proliferation of RGCs in rodent retinas in
response to alpha7 nicotinic acetylcholine receptors (nAChR) agonists.15,16
Mammalian nervous systems have an abundance of nicotinic receptors for
acetylcholine.17 For this protocol, we focused on targeting the nAChR found near the optic
nerve because there is evidence to show that these receptors are neuroprotective.1,3,4,6,18 But,
a recent study in a rodent model of glaucoma, provided evidence for the role of retinal
pigment epithelium (RPE) of responding to such compounds and inducing proliferation from
Müller glia.15,16 Most research on glaucoma has focused on the issue of IOP within the eye.
IOP is not always a consistent indicator of glaucoma or its severity, and even if the IOP is
treated, oftentimes RGCs continue to die.19 To get to the root of the problem of this disease,
we have attempted to induce proliferation of RGCs in a mixed retinal cell culture using PNU
282987. PNU 282987 has been shown to have neuroprotective properties on isolated RGCs3,
so we hypothesize that PNU 282987 will protect existing RGCs and possibly cause a
proliferation of RGCs in culture and an increase in average size and numbers due to mitosis
taking place.
Methods
Sterile Technique
The timeline for the experiment is shown in Figure 1. The porcine eyes were obtained
from DeVries Meats in Coopersville, MI. The sterile technique begins by wiping down the
hood with ~40% ethanol solution. Then place the 1000 μL pipette and pipette tips; the 200
μL pipette and pipette tips; small plastic autoclaved vials; a white-capped glass vial;
Parafilm; scissors; tape; Kimwipes; Sharpie; automatic pipette and two disposable plastic
Figure 1: Experimental
Timeline. On the first day of
the protocol, one must
sterilize the hood, clean the
eyes by removing the flesh
around the eye and ocular
nerve, dissect the eyes, plate
the cells and incubate the
plates for 48 hours. After the
48 hours, take pictures of
each of the plates.

pipette tips; autoclaved glass pipette tips and pipette bulb; Fischer plates; 100 mL beaker;
dissecting scissors; scalpel, and forceps in the hood. Turn the UV light and the blower on
with the hood slightly open for 20 minutes. Be sure to wear gloves and sterilize the gloves
with ethanol each time you enter the hood.

Preparing the Eyes
Remove the DNase, insulin (10 mg/mL), transferrin (500 µg/mL) and nerve growth
factor from the freezer to thaw. Label two 50 mL plastic centrifuge tubes Media #1 and
Media #2. Fill Media #1 with 33 mL and Media #2 with 36 mL of CO2-Independent
Medium. Add 3.5 mL of pig ringers solution to the white capped glass vial. Combine 87.5 μL
of papain with 210 μL of papain activating solution in a small autoclaved plastic vial.
Incubate the vial while dissecting. Dissect 6 retinas per protocol. First, remove the flesh
around each eye using the dissecting scissors while at the lab bench. Place the eyes in a 100
mL beaker with ice. Move to the hood for the remainder of the dissection. Turn off the UV
light and blower when dissecting.
Dissection
Use a Fischer plate to dissect the eyes, the bottom with the taller lip for dissecting, and
the top for isolating the RGCs once they have been extracted. To dissect an eye, take the
scalpel and make an incision about eight centimeters away from the iris. Gently push the eye
up against the lip of the dish for stability. Be sure to not place too much pressure on the eye.
Once the incision has been made, take the forceps and grasp the eye and use the dissecting
scissors to continue the incision around the iris until the anterior and posterior parts of the
eye are separated. Now take another set of forceps in place of the dissecting scissors and use
these to remove the thin layer of opaque RGCs from the back of the eye. Avoid extracting the
black retinal pigmented epithelium (RPE) with the RGCs. Place the RGCs in the adjacent
dish, and using the scalpel, chop up the RGCs. Transfer the RGCs to the white capped glass
vial. Clean the dishes with ethanol and wipe with Kimwipes. Repeat this process for the
remaining eyes.
Add the vial of papain and papain activating solution to the white caped vial and incubate
for 20 minutes at 37°C, shaking every 7 minutes. During incubation, label nine Fischer plates
using the Sharpie: A1, A2, A3, B1, B2, B3, C1, C2, and C3 as shown in Figure 2. Write

Figure 2: Fischer Plate Setup. The
plates were labelled A1-C3. The
plates labelled A received no PNU
282987 and were used as a control.
The plates labelled B were given 40
μL of PNU 282987. The plates
labelled C were given 80 μL of PNU
282987.

initials and date of the experiment on each plate with the number one on it. Enrich Media #2
with 75 μL of nerve growth factor, 72 μL of transferrin, and 18 μL of insulin using a 200 μL
pipette.

Plating and Incubation
After incubation, return to the hood with the white capped glass vial and add 100 μL of
DNase. Let sit for one minute. Take the glass pipette tip and begin to transfer the retina
mixture from the white-capped glass vial to the Media #1 tube. As you go, filter blood
vessels and black RPE cells out on to a paper towel. Once the filtered retina mixture has been
added to Media #1, shake Media #1 well, and using the automatic pipette to add 3 mL of the
mixture to each of the nine Fischer plates that are labelled. Be sure that the bottom of the
plates are coated evenly. Place them in the incubator at 37°C for one hour. Remove all excess
equipment from the hood except for the automatic pipette, Kimwipes, parafilm, 200 μL
pipette and pipette tips. Place the vacuum flask, its attachments, a glass pipette tip and a
clean 100 mL beaker inside the hood. Turn on the UV light and the blower on with the hood
slightly open to disinfect the hood. Remove the PNU 282987 from the fridge to thaw.
Remove the plates after one hour and return them to the hood. Use the vacuum to remove
the media from the plates. Fill the 100 mL with a small amount of ethanol. Dip the tip of the
pipette in ethanol. Gently tip each plate on an angle and touching the tip of the pipette to the
wall of the plate, not the bottom. Between each plate, dip the pipette in ethanol to disinfect.
Add 4 mL of Media #2 to each Fischer plate. Be sure that the bottom of the plates are coated
evenly as before.
The plates labelled A are the control. Add nothing to them. Add 40 μL of the PNU
282987 to the B plates. Add 80 μL of the PNU 282987 to the C plates. Cover the plates and
place them in the incubator for 48 hours at 37°C.
Imaging
Remove the plates from the incubator. Use the Nikon Eclipse E400 to image the cells.
Use the DAPI setting and the 10x magnification on the microscope. Wait for the cells to
settle and stop moving before you capture an image. Take one picture of each plate and label
them as they are labelled on the Fischer plates, A1-C3. Save them separately to a flash drive
for analysis. Use Image J to analyze the images of the plates. We used Image J to count the
cells and determine their average size in μm2.
Results
The two variables measured from the images taken were the average number of cells in
the picture of each plate and the average area of the cells. Examples of these images from
each plate are shown below in Figure 3. The cells were counted using a threshold technique
to contrast from the background.

Figure 3: Pictures of Plates A, B and C. (A) This is a sample of an image taken of an A plate. The
cells are shown against the beige background. (B) This shows an example of an image of the cells
found on a B plate. (C) This image shows the cells found on a C plate.

The A plates, the control, had an average of 1908.4 cells per picture with a standard error
of the mean of 447.125. The B plates, treated with 40 μL of PNU, had an average of
2280.095 cells per picture with a standard error of the mean of 639.98. The C plates, treated
with 80 μL of PNU, had an average of 1844.95 cells per picture with a standard error of the
mean 623.367. These values are shown in Figure 4. There appears to be an increase in cell
numbers in the B plates compared to the A plates and C plates.

Figure 4: Average Cell Count.
The A plates (control) had an
average of 1908.4 cells per
picture with a standard error of
the mean (SEM) of 447.125. The
B plates (40 μL of PNU 282987)
had an average of 2280.095 cells
per picture with an SEM of
639.98. The C plates (80 μL of
PNU 282987) had an average of
1844.95 cells per picture and an
SEM of 623.367.

The C plates had the largest average area of a cell of 362,552 μm2 with a standard error of
the mean of 158,887.7. Plates A and B have similar average area. The average area of the A
plates is 191,241.8 μm2 with a standard error of the mean of 120,262. The average area of the B
plates is 181,194.9 μm2 with a standard error of the mean of 115,988.4. These values can be seen
in Figure 5. Although the B plates appear to have the largest average area of its cells when
comparing the three plates, there was no statistical significance with this data set, so we cannot
say that there is a difference among the three variables.

Figure 5: Average Area. The
average area that the cells take
up in the pictures of the A
plates is 191,241.8 μm2 with a
SEM of 120,262. The average
area that the cells take up in
the pictures of the B plates is
181,194.9 μm2 with a SEM of
115,988.4. The average area
that the cells take up in the
pictures of plates C is 362,552
μm2 with a SEM of 158,887.7.

Discussion
The described protocol was run seven times. We compared the average cell count
between the plates to determine if mitosis had occurred since there should be more cells if
proliferation had occurred. A cellular count that is significantly higher or lower in any of the
plates would tell us if PNU 282987 was effective at stimulating mitosis in RGCs. Although it
appeared that the B plates treated with 40 μL (100 μM) of PNU 282987 did have an increase
in the cell count, Figure 3 shows that the cumulative data surrounding cell count was
statistically insignificant. We may have seen an increase in cell count in only the B plates
because 80 μL (200 μM) of PNU 282987 may have surpassed the saturation point of the
RGCs rendering the excess PNU detrimental to the RGCs. Or, the higher dose was not the
optimal dose to see an effect after the time we cultured our cells. 100 µM was found to be
most effective over a comparable time frame when examining isolated RGCs in culture.20
We compared the average cell size because a change in cell size could be considered as
potential proof of cells going through replication and thus mitotic division. The average

diameter of a RGC is between 7 and 21.5 μm21 making the range of the average area of a
RGC between 153.94 μm2 and 1452.2 μm2. However, it appears in Figure 4 that the C plates
(200 μM) had the largest cells according to the average area of 362,552 μm2. This could
indicate that mitosis was indeed occurring in the RGCs since the cells were larger compared
to the A and B plates as well as the average area of RGCs. The average cell size found on the
C plates (200 μM) were almost twice as large as the RGCs on the control plates. Although
the average area we observed for the control plates, 191,241.8 μm2, does not fit within the
expected range of the average area of an RGC, we would expect that the proper amount of
PNU 282987 would double the size of those cells due to the replication of those existing
cells.
Even though the C plates had a lower average cell count as shown in Figure 3, that could
have occurred because the cells that were amid replication had not divided yet. However,
since this data was also statistically insignificant, more data would have to be collected to
support this hypothesis. Conversely, one might expect the average cell size to be smaller after
this relatively short incubation time since it would take time for cells to grow to full size.
Limitations
Human error needs to be considered a limitation during data collection. There are four
students in the lab, and not all the protocols were done by the same student. For everyone to
get experience using the microscope, the pictures were taken by different people within the
lab. If the number of data sets had been larger, this too would have given us more accurate
data since an increased sample size reduces random error. Due to time constraints and
technical issues, only seven protocols were able to be completed for this paper.
When the plates were filled, the Media #1 was shaken, then promptly filled the plates
starting with plate A1 every time. Even though the media was shaken prior to each plate
being filled, we cannot guarantee that an equal amount of RGCs were distributed among the
nine plates. My hypothesis is that since the A plates were filled first, they received the most
RGCs. Even if there were proliferation in the plates labelled B and C, if all plates did not
start out with close to equal number of cells, then we cannot be sure that proliferation took
place or if the PNU 282987 was effective in any way. In future protocols I would suggest that
we start by filling plates B or C and then rotate to eliminate or diminish this confounding
variable. However, this was explored with isolated RGCs, and with enough shaking, no
significant difference was found using different plating routines. But one cannot rule out that
this mixed retinal cell system would be different.
Only one picture was taken of each plate and that could lead to an inaccurate
representation of the total amount of cells on each plate. The visual field of the microscope
could not cover the entire area of the plate, so we cannot be sure that the pictures taken of the
plates were an accurate representation of the cell counts on each plate. To diminish the effect
of this confounding variable, next time I would take multiple pictures of each plate. I would
take at least four pictures of each plate by turning the plate ninety degrees for each picture
taken. This is the usual protocol for the isolated RGC culture system, with images captured at
‘north, south, east and west’.
Since the cells were plated in a liquid media, they did not have the chance to adhere to
the bottom of the plate; they were suspended in the liquid. This allowed the cells to move
about freely when the plates were moved. This could have posed problems in the following
ways. When replacing Media #1 with the enriched Media #2, cells could have been removed

due to the vacuum. This could have resulted in a lower cell count in certain plates. When
imaging, the cells had to take time to settle and stop their movement within the media. We
had no control over the distribution of the cells in the plates. This could have resulted in the
images not accurately representing the typical concentration of cells throughout the entire
plate. However, with isolated RGC cultures, it was observed that cells that adhered to the
surface were more viable and floating cells were usually dead or dying.
Moving forward, we would check the circularity of the cells to ensure that we are
observing RGCs. A rating of 1 means that the cell is perfectly circular, and as the rating
approaches zero, the cell become more elliptical.22 This would function as a confirmation of
the specific cell type we have been observing. We would also increase the magnification of
the Nikon Eclipse E400 by one degree of magnification, to the 40x magnification, in order to
improve our counting of the cells and better analyze why some cells are larger than others,
for example if some cells are proceeding through mitosis or not. These are issues with this
relatively new mixed culture system and should benefit future experiments.

Conclusion
From the protocols run, we were unable to statistically determine if PNU 282987 was
successful in targeting the alpha7 nicotinic acetylcholine receptors and activating their
neuroprotective and proliferative properties. Due to the appearance of the data, we believe
that there is the potential for PNU 282987 to be preventative in the progression of glaucoma
as an effective activator of the nicotinic acetylcholine receptor and protector of RGCs. The
appropriate amount of PNU 282987 has yet to be determined to reflect results observed in
live rodents with experimentally induced glaucoma.15 The lab will continue to pursue
potential treatments for glaucoma by focusing on the direct causes of blindness such as the
death of RGCs rather than other symptoms such as increased IOP.
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